medi-551
Medi 551 is a drug used to treat Advanced B Cell Malignancies, B-cell Malignancies, Blood Cancer, and other conditions. Medi 551 is not being actively studied and prior, has been studied in 3.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| MedImmune LLC | Research Site | |
| AstraZeneca | ||
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
Completed
- B-cell Malignancies
- Cancer
- MEDI-551
- Rituximab
- Birmingham, Alabama
- +20 more
2020-04-29
Apr 29, 2020A
Completed
- Blood Cancer
- Advanced B Cell Malignancies
- MEDI-551
- Fukuoka-shi, Japan
- +2 more
2017-05-08
May 8, 2017M
Completed
- Chronic Lymphocytic Leukemia (CLL)
- Rituximab
- +2 more
- Birmingham, Alabama
- +53 more
2017-04-20
Apr 20, 2017